A safety and efficacy study of one-time SAR402663 in adults with neovascular age-related macular degeneration

Trial Identifier:	DFI17940
Sponsor:	Sanofi
Start Date:	November 2024
Primary Completion Date:	May 2027
Study Completion Date:	May 2031
Condition:	Macular Degeneration

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.